返回 Agenda
Session 6, Track C: Streamline Global Promotions: Adapt Materials and Activities for the Canadian Market
Session Chair(s)
Yulia Vasianovich, PhD, RAC
Scientific Evaluator, Marketed Health Products Directorate, Health Canada, Canada
Anna Bussel, PharmD
Vice President Pharmacovigilance and Medical Information, ClaroPV Services Inc, Canada
This session will highlight industry best practices for translating global content into Canada-ready materials and activities while strengthening safety focus, medical accuracy, and brand consistency. Participants will review key Canada-specific requirements and stakeholder expectations, including Health Canada considerations, PAAB review standards, labeling alignment, fair balance, evidence substantiation, and reference management, with particular emphasis on clear, accurate, and appropriately contextualized safety communication.
Learning Objective : - Recognize key Canadian regulatory and stakeholder expectations for communicating safety information in health product advertising
- Identify touchpoints between promotional activities and pharmacovigilance, including labelling alignment, fair balance, emerging safety information, and consistency of risk messaging
- Apply best practices for clear, accurate, balanced and appropriately contextualized safety communication in promotional materials
Speaker(s)
Streamlining Global Promotional Materials/Activities for Canada: Aligning with Regulations and Industry Best Practices
My (May) Dang, MBA
Director, Regulatory Affairs, Cencora, Canada
Speaker
Jennifer Carroll, MBA
Director, Technology and Collaborative Innovation, Pharmaceutical Advertising Advisory Board (PAAB), Canada
Speaker
Representative Invited
Senior Regulatory Policy & Risk Management Advisor, Marketed Health Products Dir, Health Canada, Canada